Mercurial > repos > devteam > dgidb_annotator
comparison test-data/out1.tabular @ 0:28d72b995c6b draft default tip
planemo upload for repository https://github.com/galaxyproject/tools-devteam/tree/master/tools/dgidb_annotator commit 5a4e0ca9992af3a6e5ed2b533f04bb82ce761e0b
| author | devteam |
|---|---|
| date | Mon, 09 Nov 2015 11:29:28 -0500 |
| parents | |
| children |
comparison
equal
deleted
inserted
replaced
| -1:000000000000 | 0:28d72b995c6b |
|---|---|
| 1 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE n/a SUNITINIB TEND | |
| 2 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE n/a IMATINIB TEND | |
| 3 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor MOTESANIB MyCancerGenome | |
| 4 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor VANDETANIB MyCancerGenome | |
| 5 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor SORAFENIB MyCancerGenome | |
| 6 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor REGORAFENIB MyCancerGenome | |
| 7 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor AMUVATINIB MyCancerGenome | |
| 8 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor SUNITINIB MyCancerGenome | |
| 9 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor CABOZANTINIB MyCancerGenome | |
| 10 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor SUNITINIB TALC | |
| 11 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor VANDETANIB TALC | |
| 12 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor MOTESANIB TALC | |
| 13 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor CABOZANTINIB TALC | |
| 14 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor REGORAFENIB TALC | |
| 15 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor LENVATINIB TALC | |
| 16 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor AMUVATINIB TALC | |
| 17 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor AT9283 TALC | |
| 18 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE n/a VANDETANIB ClearityFoundationClinicalTrial | |
| 19 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE n/a DOVITINIB ClearityFoundationClinicalTrial | |
| 20 BIRC3 gene2 BIRC3 baculoviral IAP repeat containing 3 antagonist AEG40826 TALC | |
| 21 BIRC3 gene2 BIRC3 baculoviral IAP repeat containing 3 antagonist TL 32711 TALC | |
| 22 BIRC3 gene2 BIRC3 baculoviral IAP repeat containing 3 antagonist AT-406 TALC | |
| 23 BIRC3 gene2 BIRC3 baculoviral IAP repeat containing 3 antagonist GDC0917 TALC | |
| 24 BIRC3 gene2 BIRC3 baculoviral IAP repeat containing 3 antagonist LCL161 TALC | |
| 25 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a E7449 ClearityFoundationBiomarkers | |
| 26 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a NIRAPARIB ClearityFoundationBiomarkers | |
| 27 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a OLAPARIB ClearityFoundationBiomarkers | |
| 28 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a BMN673 ClearityFoundationBiomarkers | |
| 29 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a RUCAPARIB ClearityFoundationBiomarkers | |
| 30 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a VELIPARIB ClearityFoundationBiomarkers | |
| 31 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a VANDETANIB ClearityFoundationBiomarkers | |
| 32 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a EVEROLIMUS ClearityFoundationBiomarkers | |
| 33 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a TEMSIROLIMUS ClearityFoundationBiomarkers | |
| 34 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a GDC-0973 ClearityFoundationBiomarkers | |
| 35 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a MEK162 ClearityFoundationBiomarkers | |
| 36 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a PD-325901 ClearityFoundationBiomarkers | |
| 37 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a RAFAMETINIB ClearityFoundationBiomarkers | |
| 38 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a SELUMETINIB ClearityFoundationBiomarkers | |
| 39 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a TRAMETINIB ClearityFoundationBiomarkers | |
| 40 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a CETUXIMAB ClearityFoundationBiomarkers | |
| 41 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a ERLOTINIB ClearityFoundationBiomarkers | |
| 42 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a GEFITINIB ClearityFoundationBiomarkers | |
| 43 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a PANITUMUMAB ClearityFoundationBiomarkers | |
| 44 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a PIMASERTIB ClearityFoundationBiomarkers | |
| 45 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE inhibitor REOLYSIN CancerCommons | |
| 46 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE vaccine RAS PEPTIDE CANCER VACCINE TALC |